Biogen, Inc. (BIIB)
174.40
+1.78
(+1.03%)
USD |
NASDAQ |
Jan 22, 10:58
Biogen Market Cap: 25.58B for Jan. 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 971.83B |
| AbbVie, Inc. | 385.77B |
| Stoke Therapeutics, Inc. | 1.726B |
| Alnylam Pharmaceuticals, Inc. | 49.47B |
| Insmed, Inc. | 33.45B |
Market Cap Related Metrics
| PE Ratio | 15.90 |
| PS Ratio | 2.639 |
| Price to Book Value | 1.405 |
| Price to Free Cash Flow | 11.30 |
| Price | 174.40 |
| Earnings Yield | 6.29% |
| Operating PE Ratio | 10.48 |
| Normalized PE Ratio | 14.10 |